LifeMD, Inc.
LifeMD, Inc. (LFMD) Stock Competitors & Peer Comparison
See (LFMD) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LFMD | $10.69 | +0.19% | 485.8M | -32.39 | -$0.33 | N/A |
| ONC | $291.47 | -1.68% | 33.2B | -80.29 | -$3.63 | N/A |
| INSM | $103.95 | +0.42% | 19.7B | -17.53 | -$5.93 | N/A |
| WBA | $11.61 | +0.17% | 10B | -1.59 | -$7.29 | +4.30% |
| HROWL | $25.45 | +0.86% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.28 | -0.06% | 1.4B | N/A | N/A | +11.35% |
| LFMDP | $24.02 | +0.61% | 1.1B | -10.64 | -$2.26 | N/A |
| HITI | $2.31 | -2.53% | 187.2M | -25.67 | -$0.09 | N/A |
| PETS | $3.77 | -5.28% | 77.9M | 377.00 | $0.01 | N/A |
| YI | $7.32 | -0.81% | 63.4M | -3.37 | -$2.17 | N/A |
Stock Comparison
LFMD vs ONC Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, ONC has a market cap of 33.2B. Regarding current trading prices, LFMD is priced at $10.69, while ONC trades at $291.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas ONC's P/E ratio is -80.29. In terms of profitability, LFMD's ROE is +2.33%, compared to ONC's ROE of -0.12%. Regarding short-term risk, LFMD is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check ONC's competition here
LFMD vs INSM Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, INSM has a market cap of 19.7B. Regarding current trading prices, LFMD is priced at $10.69, while INSM trades at $103.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas INSM's P/E ratio is -17.53. In terms of profitability, LFMD's ROE is +2.33%, compared to INSM's ROE of -4.47%. Regarding short-term risk, LFMD is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check INSM's competition here
LFMD vs WBA Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, WBA has a market cap of 10B. Regarding current trading prices, LFMD is priced at $10.69, while WBA trades at $11.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas WBA's P/E ratio is -1.59. In terms of profitability, LFMD's ROE is +2.33%, compared to WBA's ROE of -0.70%. Regarding short-term risk, LFMD is more volatile compared to WBA. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check WBA's competition here
LFMD vs HROWL Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, LFMD is priced at $10.69, while HROWL trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas HROWL's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to HROWL's ROE of -0.36%. Regarding short-term risk, LFMD is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check HROWL's competition here
LFMD vs HROWM Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, HROWM has a market cap of 1.4B. Regarding current trading prices, LFMD is priced at $10.69, while HROWM trades at $26.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas HROWM's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, LFMD is more volatile compared to HROWM. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check HROWM's competition here
LFMD vs LFMDP Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, LFMDP has a market cap of 1.1B. Regarding current trading prices, LFMD is priced at $10.69, while LFMDP trades at $24.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas LFMDP's P/E ratio is -10.64. In terms of profitability, LFMD's ROE is +2.33%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, LFMD is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check LFMDP's competition here
LFMD vs HITI Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, HITI has a market cap of 187.2M. Regarding current trading prices, LFMD is priced at $10.69, while HITI trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas HITI's P/E ratio is -25.67. In terms of profitability, LFMD's ROE is +2.33%, compared to HITI's ROE of -0.07%. Regarding short-term risk, LFMD is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check HITI's competition here
LFMD vs PETS Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, PETS has a market cap of 77.9M. Regarding current trading prices, LFMD is priced at $10.69, while PETS trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas PETS's P/E ratio is 377.00. In terms of profitability, LFMD's ROE is +2.33%, compared to PETS's ROE of +0.00%. Regarding short-term risk, LFMD is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check PETS's competition here
LFMD vs YI Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, YI has a market cap of 63.4M. Regarding current trading prices, LFMD is priced at $10.69, while YI trades at $7.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas YI's P/E ratio is -3.37. In terms of profitability, LFMD's ROE is +2.33%, compared to YI's ROE of +0.11%. Regarding short-term risk, LFMD is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check YI's competition here
LFMD vs RAD Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, LFMD is priced at $10.69, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas RAD's P/E ratio is -0.05. In terms of profitability, LFMD's ROE is +2.33%, compared to RAD's ROE of +2.76%. Regarding short-term risk, LFMD is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check RAD's competition here
LFMD vs RNTX Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, RNTX has a market cap of 32.3M. Regarding current trading prices, LFMD is priced at $10.69, while RNTX trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas RNTX's P/E ratio is -0.50. In terms of profitability, LFMD's ROE is +2.33%, compared to RNTX's ROE of -1.12%. Regarding short-term risk, LFMD is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check RNTX's competition here
LFMD vs ATNFW Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, ATNFW has a market cap of 16.1M. Regarding current trading prices, LFMD is priced at $10.69, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas ATNFW's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to ATNFW's ROE of -1.41%. Regarding short-term risk, LFMD is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check ATNFW's competition here
LFMD vs NEUP Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, NEUP has a market cap of 16M. Regarding current trading prices, LFMD is priced at $10.69, while NEUP trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas NEUP's P/E ratio is 0.45. In terms of profitability, LFMD's ROE is +2.33%, compared to NEUP's ROE of +0.31%. Regarding short-term risk, LFMD is more volatile compared to NEUP. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check NEUP's competition here
LFMD vs MEDS Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, LFMD is priced at $10.69, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas MEDS's P/E ratio is -0.31. In terms of profitability, LFMD's ROE is +2.33%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, LFMD is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check MEDS's competition here
LFMD vs CJJD Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, LFMD is priced at $10.69, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas CJJD's P/E ratio is -0.46. In terms of profitability, LFMD's ROE is +2.33%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, LFMD is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check CJJD's competition here
LFMD vs SSY Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, SSY has a market cap of 9.6M. Regarding current trading prices, LFMD is priced at $10.69, while SSY trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas SSY's P/E ratio is -3.49. In terms of profitability, LFMD's ROE is +2.33%, compared to SSY's ROE of +0.12%. Regarding short-term risk, LFMD is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check SSY's competition here
LFMD vs MDVL Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, LFMD is priced at $10.69, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas MDVL's P/E ratio is -0.05. In terms of profitability, LFMD's ROE is +2.33%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, LFMD is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for LFMD.Check MDVL's competition here
LFMD vs LFLY Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, LFLY has a market cap of 626.5K. Regarding current trading prices, LFMD is priced at $10.69, while LFLY trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas LFLY's P/E ratio is -0.11. In terms of profitability, LFMD's ROE is +2.33%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, LFMD is more volatile compared to LFLY. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check LFLY's competition here
LFMD vs LFLYW Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, LFLYW has a market cap of 539.6K. Regarding current trading prices, LFMD is priced at $10.69, while LFLYW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas LFLYW's P/E ratio is -0.06. In terms of profitability, LFMD's ROE is +2.33%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, LFMD is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check LFLYW's competition here
LFMD vs BIMI Comparison July 2025
LFMD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFMD stands at 485.8M. In comparison, BIMI has a market cap of 2.8K. Regarding current trading prices, LFMD is priced at $10.69, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFMD currently has a P/E ratio of -32.39, whereas BIMI's P/E ratio is N/A. In terms of profitability, LFMD's ROE is +2.33%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, LFMD is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for LFMD.Check BIMI's competition here